Oncology Books

2618 products


  • Leben mit Krebs: Praktischer Ratgeber für

    Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Leben mit Krebs: Praktischer Ratgeber für

    Out of stock

    Book SynopsisKrebserkrankte, ihre Angehörigen sowie Freunde und Behandler erhalten in diesem Ratgeber einfache und verständliche Informationen zu wichtigen Aspekten von Krebserkrankungen. Die Themenauswahl basiert auf der Aachener Veranstaltungsreihe "leben mit krebs", welche ganz nah an den Bedürfnissen der Besucher ausgerichtet ist und geht weit über die rein medizinische Versorgung hinaus. Dieses Buch unterstützt bei der Bewältigung einer Krebserkrankung und ihrer Folgen, vermittelt Informationen wie beispielsweise zu Angstbewältigung, Ernährung und Bewegung, Sexualität und Patientenverfügung auf verständliche Art und ermutigt zur eigenen Informiertheit. Praktische Tipps und Hilfestellungen für häufig nicht offen angesprochene Situationen des "Alltags" erleichtern Austausch und Gespräche zwischen allen Beteiligten. Die Autoren greifen auf ihren reichen Erfahrungsschatz aus der Behandlung von Krebspatienten und aus der Veranstaltungsreihe "leben mit krebs" zurück.Trade Review“... Mir war es ein Vergnügen, diese Ratgeber-Broschüre zu lesen. Während der Lektüre stellte sich wiederholt der Wunsch ein, die Broschüre neben den Patienten und Patientinnen ebenfalls allen Pesonen [sic], die professionell in der Betreuung von Menschen mit Krebserkrankungen tätig sind, ans Herz zu legen und nicht zuletzt auch in den Unterricht von Studierenden zu integrieren.” (M. Von Lilienfeld-Toal, in: best practice onkologie, Heft 4, April 2022)Table of ContentsÜber- „leben mit krebs.- Hoffnung auf ein gutes Leben während und nach einer Krebserkrankung.- Hoffnung auf gesundes Leben.- Hoffnung auf ein abgesichertes Leben.- Hoffnung für spezielle Gruppen.- Hoffnung auf Alltag.

    Out of stock

    £999.99

  • Psychosoziale Uroonkologie

    Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Psychosoziale Uroonkologie

    1 in stock

    Book SynopsisCirca jeder 3. Patient in der Urologie ist ein Tumorpatient. In der Uroonkologie sind es meist ältere, an Prostatakrebs erkrankte Männer, die nicht gelernt haben, über Ihre Gefühle zu sprechen. Aber auch jüngere Männer leiden, besonders unter begleitenden sexuellen Funktionsstörungen.In diesem Praxisbuch werden die Grundlagen der psychosozialen Uroonkologie erläutert wie auch die Diagnostik und Therapie. Es schildert die Besonderheiten der männlichen Patientengruppe, stellt die wichtigsten Tumorentitäten kurz dar und richtet den Blick auch auf psychische Komorbiditäten. Intensiv werden Patientenängste, z. B. Progredienzangst, Sexualität, Tod thematisiert und Sie erhalten zahlreiche Tipps, wie Sie ein Patientengespräch führen und Hilfen anbieten können. Hinweise und Übersichten für den Arbeitsalltag zur Diagnostik und Therapie und Praxistipps zum Umgang mit der meist älteren, männlichen Patientengruppe erleichtern die Gesprächsführung und erweitern das Hilfsangebot für den Patienten. Das Buch basiert auf der Fachexpertise eines renommierten Autorenteams und spiegelt den aktuellen Stand der Wissenschaft wider. Es erfolgen viele Verweise und Erläuterungen zur S3-Leitlinie „Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten“.Für Urologen, Onkologen, Psychotherapeuten und jeden Arzt, der urologische Tumorpatienten behandelt, und diesen wertvollen Baustein in der Krebstherapie professionell nutzt - für mehr Lebensqualität des Patienten. Trade Review“... Zu den Besonderheiten der Urologie schließt das vorgestellte Lehrbuch die bislang als deutlich wahrgenommene Lücke in der psychoonkologischen Literatur auf Fachbuch-Ebene. Den Herausgebern und neun weiteren Autoren ist es hervorragend gelungen, die psychosoziale Uroonkologie in allen relevanten Facetten darzustellen. Die komplexe Thematik wird auf 220 Seiten sehr übersichtlich unter Verwendung verständlicher Schemata und informativer Abbildungen kompetent, kompakt und interessant vermittelt — Lehrbuch und Nachschlagewerk gleichermaßen ...” (Dieter Jocham, in: Der Urologe, 1. April 2023) Table of ContentsGrundlagen der psychosozialen Uroonkologie.- Psychische Komorbiditäten.- Psychoonkologische Diagnostik.- Das bio-psychosoziale Konzept.- S3-Leitlinie.- Psychosoziale Belastung bei urolog. Tumorerkrankungen.- Psychosoziale Interventionen.- Behandlungsmethoden.- Krebs und Familie.- Krebs und Sexualität.- Krebs und Beruf.- Psychoonkologische Versorgungsstrukturen.

    1 in stock

    £37.99

  • Der moderne Krebs - Lifestyle und Umweltfaktoren

    Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Der moderne Krebs - Lifestyle und Umweltfaktoren

    Out of stock

    Book SynopsisRenommierte Heidelberger Wissenschaftler haben in diesem Buch zusammengetragen, was heute über Krebserkrankungen und ihre Ursachen bekannt ist. Lediglich 5 bis 10% aller Krebserkrankungen werden durch vererbte Gendefekte verursacht. Epidemiologische und experimentelle Daten aus wissenschaftlichen Studien und Hochrechnungen zeigen, wie sehr das Erkrankungsrisiko durch die eigene moderne Lebensweise beeinflusst wird. Die Autoren haben sich zum Ziel gesetzt, diffusen Ängsten und gefährlichem Halbwissen wissenschaftlich valides Wissen entgegenzusetzen und diese Daten und Fakten verständlich und unterhaltsam zu präsentieren. Das Buch richtet sich an alle medizinisch Interessierten, Betroffene und Angehörige.Table of ContentsNeuigkeiten aus der Krebsforschung.- Ein beunruhigender Trend.- Das Immunsystem und Krebs.- Was uns HIV und Organspenden über den Krebs verraten.- Krebsfördernde Umwelteinflüsse und Erkrankungen.- Alter und Krebs.- Zucker, Fette und Übergewicht.- Bewegungsmangel als Krebsursache.- Ernährung und Darmkrebs.- Infektiöse Erreger in Rindfleisch und Kuhmilch?.- Stress und Krebs.- Entzündungshemmer, Vitamine und Antioxidantien.- Krebsprävention - Allheilmittel und Anti-Aging-Therapie.- Die Therapie der Zukunft.- Personalisierte Medizin: die richtige Therapie für den richtigen Patienten zur richtigen Zeit.- Ein Denkmal für die Maus.- Schlusswort.- Danksagung.

    Out of stock

    £999.99

  • Springer Verlag GmbH Grundlagen der Chemotherapie

    Out of stock

    Book SynopsisTable of ContentsErstes Kapitel. Chemotherapie — Definition und Geschichte.- 1. Der Begriff Chemotherapie.- 2. Die Entwicklung der Chemotherapie.- 2.1. Erste Studien mit Trypanosomen und Treponemen.- 2.2. Die Postulate Paul Ehrlichs.- 2.3. Sulfonamide: Durchbruch zur antibakteriellen Chemotherapie.- 2.4. Penicillin und andere Antibiotika.- 2.5. Antifungale Chemotherapie.- 2.6. Chemotherapie maligner Erkrankungen.- 2.7. Antivirale Chemotherapie.- Literatur.- Zweites Kapitel. Chemotherapeutische Grundbegriffe.- 1. Chemotherapeutika und Antibiotika.- 2. Wie wirken Chemotherapeutika.- 2.1. Wirkung in vitro.- 2.1.1. Wirkungsspektrum.- 2.1.2. Wirkungsintensität.- 2.1.3. Wirkungstypen: Cytozidie und Cytostase.- 2.2. Wirkung in vivo.- 2.2.1. Tierversuche.- 2.2.2. Wirkung und Toxizität: der chemotherapeutische Quotient.- 2.2.3. Persistenz.- 3. Klinisch-pharmakologische Aspekte.- 3.1. Wirkstoffkonzentration in vivo: Blutspiegel.- 3.2. Verteilung des Wirkstoffes im Organismus.- 3.3. Invasion und Elimination.- 3.4. Metabolismus.- 3.5. Eiweißbindung.- 3.5.1. Eiweißbindung und Wirksamkeit.- 3.5.2. Eiweißbindung und Verteilung.- 3.5.3. Eiweißbindung und Ausscheidung.- 4. Strategische Aspekte der Chemotherapie am Beispiel der antimikrobiellen Chemotherapie.- 4.1. Diagnose, Erregernachweis.- 4.2. Feststellung der Empfindlichkeit oder Resistenz des Erregers.- 4.3. Wahl des Chemotherapeutikums, Dosierung, Applikationsart.- 4.4. Therapiekontrolle durch Laboruntersuchungen.- 4.5. Chemoprophylaxe.- 4.6. Besonderheiten der Tumorchemotherapie.- Literatur.- Drittes Kapitel. Wirkungsmechanismus von Chemotherapeutika und Antibiotika.- 1. Hemmstoffe der bakteriellen Zellwandbiosynthese.- 1.1. Aufbau der bakteriellen Zellwand.- 1.2. Bedeutung des Mureingerüstes.- 1.3. Die Mureinbiosynthese.- 1.4. Hemmstoffe der Mureinbiosynthese.- 1.4.1. Phosphonomycin.- 1.4.2. Cycloserin.- 1.4.3. Vancomycin.- 1.4.4. ?-Lactamantibiotika.- 1.4.5. Bacitracin.- 1.4.6. Phosphoglykolipidantibiotika.- 1.4.7. Polyoxine, Hemmstoffe der Chitinbiosynthese.- 2. Die Interaktion antimikrobieller Wirkstoffe mit der Zellmembran.- 2.1. Die Cytoplasmamembran.- 2.2. Polymyxine und verwandte zyklische Peptide.- 2.3. Polyenantibiotika.- 2.4. Ionophore.- 3. Hemmstoffe des Folsäurestoffwechsels.- 3.1. Sulfonamide.- 3.2. Hemmstoffe der Dihydrofolat-Reduktase.- 3.2.1. Methotrexat und Aminopterin.- 3.2.2. Trimethoprim und Pyrimethamin.- 4. Hemmstoffe und Biosynthese von Nukleinsäuren.- 4.1. Hemmstoffe des Nukleotidstoffwechsels.- 4.2. Eingriff in die Matrizenfunktion der DNS.- 4.2.1. Interkalierende Stoffe.- 4.2.2. Bindung an DNS durch andere nicht kovalente Mechanismen.- 4.2.3. Vernetzung der DNS-Stränge: Mitomycin und Porfiromycin.- 4.2.4. Alkylierende Agentien.- 4.2.5. Bleomycin: Erzeugung von Strangbrüchen in der DNS.- 4.2.6. Hemmstoffe von Polymerasen und anderen Enzymen des Nukleinsäurestoffwechsels.- 4.2.6.1. Hemmstoffe der RNS-Polymerase (Rifamycine).- 4.2.6.2. Hemmstoffe der DNS-Polymerase.- 4.2.6.3. Hemmstoffe viruscodierter DNS-Polymerase.- 5. Hemmstoffe der Proteinbiosynthese.- 5.1. Der Aufbau des Ribosoms in Bakterien und höheren Zellen.- 5.2. Mechanismus der Proteinbiosynthese in Bakterien und in höheren Zellen.- 5.3. Hemmstoffe, die an der kleinen ribosomalen Untereinheit angreifen.- 5.3.1. Aurintricarbonsäure.- 5.3.2. Aminoglykoside.- 5.3.3. Tetracycline.- 5.4. Hemmstoffe, die an der großen ribosomalen Untereinheit angreifen.- 5.4.1. Chloramphenicol.- 5.4.2. Makrolide.- 5.4.3. Lincosamide.- 5.4.4. Pleuromutiline.- 5.4.5. Cycloheximid.- 5.4.6. Fusidinsäure.- 5.4.7. Thiostrepton.- 6. Spindelgifte.- 6.1. Colchicin.- 6.2. Podophyllotoxin.- 6.3. Vincaalkaloide.- 6.4. Griseofulvin.- 6.5. Benzimidazole.- 7. Hormone als Chemotherapeutika.- 7.1. Biochemische Wirkungsweise von Steroidhormonen.- 7.2. Der Wirkungsmechansimus von Glucocorticoiden im lymphatischen Zellen.- Literatur.- Viertes Kapitel. Das Problem der Selektivität in der Chemotherapie.- 1. Biochemische Aspekte der Selektivität.- 1.1. Selektivität durch Unterschiede in den Wechselwirkungen zwischen Wirkstoff und Chemorezeptoren.- 1.1.1. Abwesenheit des spezifischen Chemorezeptors im Wirtsorganismus.- 1.1.2. Verschiedenartigkeit der relevanten Chemorezeptoren im Wirtsorganismus und im Parasiten.- 1.1.3. Unterschiede in der Konzentration des Chemorezeptors.- 1.2. Selektivität durch Unterschiede in der Wirkstoffkonzentration.- 1.2.1. Permeabilitätsunterschiede.- 1.2.2. Umwandlung eines Wirkstoffes in seine aktive Form am Ort der Wirkung.- 1.2.3. Geschwindigkeit des Wirkstoffabbaus.- 1.3. Unterschiede in den Auswirkungen der Interaktion zwischen Wirkstoff und Rezeptor.- 1.3.1. Vollständigkeit der Inhibierung.- 1.3.2. Intrazellulärer Vorrat an kritischen Metaboliten.- 1.3.3. Geschwindigkeit von Reparationsvorgängen.- 1.3.4. Funktion des Chemorezeptors für Teilung und Lebensfähigkeit der Zelle.- 2. Cytokinetische Aspekte der Selektivität.- 2.1. Der Zyklus der Zellteilung.- 2.2. Zyklusspezifische und -unspezifische Wirkstoffe.- 2.3. Unterschiedliche Reaktionen normaler und maligner Zellpopulationen auf cytotoxische Substanzen.- Literatur.- Fünftes Kapitel. Resistenzprobleme.- 1. Der Resistenzbegriff.- 1.1. „Natürliche“ und erworbene Resistenz.- 2. Adaption, Mutation und Selektion.- 3. Genetische Mechanismen der Resistenzentstehung.- 3.1. Mutation.- 3.1.1. Mutationsfrequenz.- 3.1.2. Einfache und mehrfache Mutationen.- 3.1.3. Kreuzresistenz und „kollaterale Sensitivität“.- 3.2. Übertragung externer genetischer Information.- 3.2.1. Episomale Resistenz — Resistenzfaktoren.- 3.2.1.1. Entdeckung der Resistenzfaktoren.- 3.2.1.2. Physikochemische und genetische Eigenschaften der Resistenzfaktoren.- 3.2.1.3. Verbreitung und Epidemiologie.- 4. Biochemische Mechanismen der Resistenzentstehung.- 4.1. Veränderung von Zellbestandteilen.- 4.1.1. Herabgesetzte Bindung am Wirkort.- 4.1.2. Herabgesetzte Zellpermeabilität.- 4.1.3. Ausbleiben der „letalen Synthese“.- 4.1.4. Umgehung von Biosyntheseblocks.- 4.2. Inaktivierung des Wirkstoffes.- 4.2.1. Antibiotika-inaktivierende Enzyme in Bakterien.- 4.2.2. Inaktivierung von Wirkstoffen in höheren Zelllen.- 5. Vermeidung und Umgehung von Resistenz.- 5.1. Epidemiologisch wirksame Maßnahmen.- 5.2. Vermeidung enzymatischer Inaktivierungsmechanismen.- 5.3. Wege zur Umgehung oder Durchbrechung Plasmid-codierter Resistenz in der antibakteriellen Chemotherapie.- Literatur.- Sechstes Kapitel. Kombinierte Chemotherapie.- 1. Additive Wirkung — Synergismus — Antagonismus.- 2. Biochemische Voraussetzungen für synergistische Wirkungen.- 3. Argumente für die Kombination antimikrobieller Wirkstoffe.- 4. Risiken der Kombination von Wirkstoffen in der antimikrobiellen Chemotherapie.- 5. Besonderheiten der Kombination von Wirkstoffen in der Tumorchemotherapie.- 5.1. „Therapia magna sterilisans“.- 5.2. Synergismus in der Tumorchemotherapie.- 5.3. Biochemische und cytokinetische Grundlagen für die Kombination von Wirkstoffen.- 5.4. Vermeidung der Selektion resistenter Klone.- Literatur.- Siebtes Kapitel. Die Suche nach neuen Chemotherapeutika.- 1. Abwandlung bekannter Strukturen — molekulare Manipulation.- 2. Die Suche nach neuen Naturstoffen: Screening auf Antibiotika.- 3. „Gezielte“ Synthese neuer Verbindungen.- 4. Quantitative Struktur-Wirkungsbeziehungen.- 5. Blindes Screening.- 6. Therapeutische Ziele — adäquate Modelle.- Literatur.- Achtes Kapitel. Grenzen der Chemotherapie.- 1. Unerwünschte Nebenwirkungen von Antibiotika und Chemotherapeutika.- 1.1. Überempfindlichkeitsreaktionen.- 1.2. Direkte toxische Wirkungen von Chemotherapeutika und Antibiotika.- 1.3. Typische Nebenwirkungen antineoplastischer Substanzen.- 2. Chemotherapie und Immunantwort.- 2.1. Immundefekte.- 2.2. Möglichkeiten zur Steigerung der Immunantwort.- 3. Chemotherapie und Umwelt.- 3.1. Einfluß der Chemotherapie auf die mikrobielle Ökologie.- 3.2. Hospitalismus.- 3.3. Die Verwendung von Antibiotika und Chemotherapeutika in der Landwirtschaft und Tierernährung.- 4. Chemotherapeutika als Cancerogene.- Literatur.

    Out of stock

    £71.99

  • Supportivtherapie in der Onkologie

    Urban und Vogel Supportivtherapie in der Onkologie

    15 in stock

    Book SynopsisHeute erfordert eine adäquate onkologische Therapie nicht nur tumorspezifisches Fachwissen, sondern auch spezifische Kenntnisse supportiver Maßnahmen, insbesondere über Prophylaxe und Behandlung relevanter Nebenwirkungen der onkologischen Therapien. Auch der Einsatz psychoonkologischer Methoden, ethische Fragen sowie Sinn und Zweck der Palliativmedizin und der Rehabilitation sind Themen, die alle in der Betreuung Krebskranker Tätigen beschäftigen. So unterschiedlich die Thematik der einzelnen Kapitel ist: das gemeinsame Ziel ist, die Lebensqualität Krebskranker in allen Stadien ihrer Erkrankung zu verbessern.

    15 in stock

    £31.34

  • Thieme Medical Publishers Clinical Oncology: Viva Voce, OSCEs, and ESMO

    Out of stock

    Book Synopsis

    Out of stock

    £32.30

  • Gastric Cancer: With Special Focus on Studies

    Springer Verlag, Singapore Gastric Cancer: With Special Focus on Studies

    Out of stock

    Book SynopsisThis book provides essential insights into the various pathogeneses, diagnoses and therapies for patients with gastric cancer. Special attention is given to trending topics: endoscopic diagnosis, cancer screening and eradication of H. pylori as prevention of the disease. A dedicated section focuses on risk classification and cancer screening/diagnosis, and is intended for practical use in clinical doctors’ day-to-day management of patients. Since cancer screening and prevention is currently only practiced in Japan, this book is intended to disseminate new findings and serve as a point of departure for further research. Abundant color illustrations of the enhanced endoscopic imaging are also included, making it a valuable resource for GI medical doctors, medical students and those seeking detailed information on H. pylori.​ Trade Review Table of ContentsPreface.- Part I Epidemiology.- Chapter 1 Japan.- Chapter 2 Outside Japan.- Part II Pathogenesis .- Chapter 3 Helicobacter Pylori.- Chapter 4 Gastric Carcinogenesis.- Chapter 5 Pathology.- Part III Risk Clarification and Cancer Screening Before and After Eradication.- Chapter 6 Serum Markers.- Chapter 7 High Risk Markers.- Chapter 8 Cancer Screening.- Chapter 9 Endoscopy.- Part IV Therapy.- Chapter 10 Endoscopic Treatment.- Chapter 11 Surgical Treatment.- Chapter 12 Chemotherapy.- Part V Prevention.- Chapter 13 H. Pylori Eradication.- Chapter 14 Prevention Strategy

    Out of stock

    £71.99

  • Skin Cancer: Pathogenesis and Diagnosis

    Springer Verlag, Singapore Skin Cancer: Pathogenesis and Diagnosis

    Out of stock

    Book SynopsisThis book highlights the molecular and cellular mechanisms involved in the initiation and progression of skin cancer. It also explains the role of the environment in skin cancer development and explores the potential of microbiome in the diagnosis, prevention and treatment of skin cancer. The book also presents potential biomarkers for early detection of skin cancer and discusses recent advances in skin cancer prevention and treatment using photodynamic therapy. Lastly, it summarizes the applications of biomedical engineering, non-coding and nanotechnology in the diagnosis and therapeutics in skin cancer. It is a valuable resource for investigators in the field of skin cancer, including pathologists, medical and surgical oncologists, and dermatologists.Table of ContentsChapter 1. Cancer of the Skin:Type and Etiology.- Chapter 2. Therapeutic intervention in skin cancer: Future prospects.- Chapter 3. Melanin Based Classification of Skin Types and Their Susceptibility to UV-induced Cancer.- Chapter 4. The Epidemiology of Skin Cancer Worldwide.- Chapter 5. UV-R induced Vitamin D synthesis and skin cancer.- Chapter 6. The role of microbiome in the induction, diagnosis and therapy of skin cancer.- Chapter 7. Skin Cancer: Molecular Biomarker for Diagnosis, Prognosis, Prevention and Targeted Therapy.- Chapter 8. Therapeutics intervention of skin cancer in the OMICS era.- Chapter 9. Artificial intelligence in Skin Cancer: Diagnosis and Therapy.- Chapter 10. Biomedical engineering in cancer diagnosis and therapy.- Chapter 11. Skin cancer treatment with Emphasis on Nanotechnology.- Chapter 12. Non-long coding RNA and role in skin cancer diagnosis and therapy.- Chapter 13. Potential of long non-coding RNAs in the diagnosis and therapy of melanoma skin cancer.-

    Out of stock

    £999.99

  • Color Atlas of Laparoscopic Liver Resection

    Springer Verlag, Singapore Color Atlas of Laparoscopic Liver Resection

    Out of stock

    Book SynopsisThis atlas describes and illustrates in detail the surgical procedures employed in laparoscopic anatomical liver resection, according to tumor location. The surgical approach and techniques are explained for each type of laparoscopic liver resection based on the involved anatomical segment, section, and hemi-liver. Attention is also drawn to potential complications and the means of preventing and managing them. Beyond anatomical liver resection, guidance is provided on non-anatomical resections that do not pay regard to segmental, sectional, or lobar anatomy. The coverage is completed by the inclusion of useful information on instruments and energy devices as well as the basic skills required for laparoscopic liver resection. In presenting a clear practical approach to each laparoscopic anatomical major and minor resection, the Color Atlas of Laparoscopic Liver Resection will be an invaluable guide for trainees. In addition, it will equip more experienced surgeons with much useful information that will enable them to further improve their technique.Table of Contents1. Introduction.- 2. Instruments and energy devices for laparoscopic liver resection.- 3. Basic skills for laparoscopic liver resection.- 4. Anatomical liver resection.- 5. Non-anatomical liver resection.- 6. Others.

    Out of stock

    £999.99

  • Obesity and Cancer

    Springer Verlag, Singapore Obesity and Cancer

    Out of stock

    Book SynopsisThis book highlights the concordance between signaling pathways that are involved in obesity and cancer cross-talks. It describes the role of cytokines, chemokines, growth factors, insulin, and adipokines in the development of obesity-associated cancers. The book reviews the role of inflammatory signaling pathways such as estrogen-mediated signaling, mTOR and AMP-activated protein kinase pathway and the involvement of adaptive and innate immunity, oxidative stress, gene polymorphism, dietary phytochemicals, and miRNAs in obesity and cancer. In addition, it covers the latest research on the drugs and natural therapeutic agents that target obesity-induced cancers and discusses various in vivo models for studying obesity and obesity-associated cancer. Lastly, it analyses the role of genetic polymorphisms in the obesity-related genes that influence cancer development. The book is a useful resource for researchers in the field of cancer, pharmacology, food chemistry, and clinical biochemistry. Table of ContentsChapter 1. Obesity induced chronic low-level inflammation and cancers.- Chapter 2. Adipose tissue produced estrogen as risk factor for cancers.- Chapter 3. Insulin and Insulin-like growth factor-1 associated cancers.-Chapter 4. Adipokines play important role in cell proliferation and antiproliferation.- Chapter 5. mTOR and AMP-activated protein kinase in obesity and cancer.- Chapter 6. Immune response and oxidative stress in obesity induced cancer.- Chapter 7. Role of gene polymorphism in obesity and cancer.- Chapter 8. Therapeutic role of green tea in obesity and cancer.- Chapter 9. Effect of dietary phytochemicals in obesity and cancer.- Chapter 10. Resveratrol as anti-obesity and anticancer agent.- Chapter 11. EGCG as anti-obesity and anticancer agent.- Chapter 12. miRNAs as therapeutic target in obesity and cancer.- Chapter 13. In silico updates on lead identification for obesity and cancer.- Chapter 14. In vivo models for obesity and obesity related carcinogenesis.- Chapter 15. Estrogen signaling based current and potential therapies against obesity and related diseases.- Chapter 16. Autophagy at the crossroad of obesity mediated cancer progression.

    Out of stock

    £999.99

  • Management of Pancreatic Cancer and

    Springer Verlag, Singapore Management of Pancreatic Cancer and

    Out of stock

    Book SynopsisThis comprehensive book presents the latest evidence-based data on pancreatobiliary malignancies, including the epidemiology, examination, treatment and endoscopic management. It explores a range of topics, such as risk factors, detection strategies, and novel treatment approaches like precision medicine and immunotherapy.Although there have been rapid improvements in the management of these diseases, the survival period has not yet reached a satisfactory level. This book will help those doctors needing to share the latest information with the patients and their families. It provides a wealth of practical information to help surgeons, endoscopists and oncologists as well as physicians, basic researchers and professionals at medical device and pharmaceutical companies broaden their understanding of the current treatment and management strategies for pancreatobiliary malignancies.Table of ContentsPart I Current topics in Epidemiology and Examinations of Pancreatic Cancer and Cholangiocarcinoma 1 Risk Factors for Pancreatic Cancer and Cholangiocarcinoma 2 Detection strategies and examination of early pancreatic cancer 3 Biomarkers for Pancreatic Cancer and Cholangiocarcinoma 4 Recent advances of precision medicine in pancreatic cancer and and cholangiocarcinoma Part II Anti-cancer Treatments for Pancreatic Cancer 5 Chemotherapy for locally advanced and metastatic pancreatic cancer 6 Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer 7 Adjuvant Chemotherapy for Pancreatic Cancer 8 Conversion Surgery in Pancreatic Cancer 9 Radiotherapy for pancreatic cancer Part III Anti-cancer Treatments for Cholangiocarcinoma 10 Chemotherapy for Unresectable Cholangiocarcinoma 11 Adjuvant chemotherapy for cholangiocarcinoma 12 Neoadjuvant therapy and conversion surgery for cholangiocarcinoma 13 Radiotherapy for Cholangiocarcinoma Part IV New Treatment for Pancreatic Cancer and Cholangiocarcinoma 14 Precision medicine for pancreatic cancer and cholangiocarcinoma 15 Immunotherapy for pancreatic cancer and biliary tract cancer 16 Treatment approach for pancreatic ductal adenocarcinoma with peritoneal dissemination 17 Treatment strategies for frail and elderly patients with pancreatic cancer Part V Endoscopic Management of Pancreatic Cancer and Cholangiocarcinoma 18 Endoscopic diagnosis of pancreatic cancer and cholangiocarcinoma 19 Preoperative biliary drainage for pancreatic cancer and cholangiocarcinoma 20 ERCP for malignant biliary obstruction for unresectable pancreatic cancer and cholangiocarcinoma 21 Interventional EUS for pancreatic cancer and cholangiocarcinoma 22 Novel endoscopic focal therapy for pancreatic cancer and cholangiocarcinoma 23 Endoscopic management of gastrointestinal obstruction from pancreaticobiliary cancer 24 Development of Self-expandable Biliary Metal Stents for Pancreatic Cancer and Cholangiocarcinoma

    Out of stock

    £999.99

  • Hereditary Breast and Ovarian Cancer: Molecular

    Springer Verlag, Singapore Hereditary Breast and Ovarian Cancer: Molecular

    Out of stock

    Book SynopsisThis highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease. Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.Table of Contents1 History, Advancements, and Future Strategies 2 Molecular basis of BRCA1 and BRCA2 - Homologous recombination deficiency and tissue-specific carcinogenesis 3 Genetic Testing 4 Variants of uncertain significances in hereditary breast and ovarian cancer 5 Genetic counseling in Hereditary Breast and Ovarian Cancer 6 Hereditary Breast Cancer 7 Hereditary Ovarian Cancer 8 Risk-Based Breast Cancer Screening 9 Chemoprevention for Breast Cancer 10 Chemoprevention for Ovarian Cancer 11 Risk-Reducing Mastectomy (RRM) 12 Risk-reducing salpingo-oophorectomy (RRSO) 13 Panel Testing 14 Germline Findings through Precision Oncology for Ovarian Cancer 15 Germline Findings from Genetic Testing for Breast Cancer 16 Hereditary Breast and Ovarian Cancer (HBOC) Database 17 Ethical Issues: Overview in Genomic analysis and Clinical Context 18 PARP Inhibitors-Mechanism of action 19 PARPi - Efficacy in Hereditary Breast Cancer 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer

    Out of stock

    £74.99

  • Hereditary Breast and Ovarian Cancer: Molecular

    Springer Verlag, Singapore Hereditary Breast and Ovarian Cancer: Molecular

    15 in stock

    Book SynopsisThis highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease. Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.Table of Contents1 History, Advancements, and Future Strategies 2 Molecular basis of BRCA1 and BRCA2 - Homologous recombination deficiency and tissue-specific carcinogenesis 3 Genetic Testing 4 Variants of uncertain significances in hereditary breast and ovarian cancer 5 Genetic counseling in Hereditary Breast and Ovarian Cancer 6 Hereditary Breast Cancer 7 Hereditary Ovarian Cancer 8 Risk-Based Breast Cancer Screening 9 Chemoprevention for Breast Cancer 10 Chemoprevention for Ovarian Cancer 11 Risk-Reducing Mastectomy (RRM) 12 Risk-reducing salpingo-oophorectomy (RRSO) 13 Panel Testing 14 Germline Findings through Precision Oncology for Ovarian Cancer 15 Germline Findings from Genetic Testing for Breast Cancer 16 Hereditary Breast and Ovarian Cancer (HBOC) Database 17 Ethical Issues: Overview in Genomic analysis and Clinical Context 18 PARP Inhibitors-Mechanism of action 19 PARPi - Efficacy in Hereditary Breast Cancer 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer

    15 in stock

    £116.99

  • Cancer Diagnostics and Therapeutics: Current

    Springer Verlag, Singapore Cancer Diagnostics and Therapeutics: Current

    Out of stock

    Book SynopsisThis book presents multiple facets of cancer biology, including cancer diagnosis, therapeutics to the latest developments in cancer informatics, and applications of artificial intelligence for improving oncologic care. The initial section of the book discusses factors contributing to the development and causes of cancer. The subsequent sections discuss the basic principle of imaging and therapeutic techniques, including MRI, CT, and positron emission tomography (PET) Scan. The book further, explores the implications of cancer chemotherapy on the immune system and emphasizes the effective management of cancer-related pain. Towards the end, it covers recent advancements in cancer treatment, including targeted therapy, immunotherapy, interventional radiotherapy, and stem cell-based therapy. Lastly, it summarizes essential strategic elements of cancer informatics for improving patient outcome.Table of ContentsChapter 1_ introductory cancer biology. –Chapter 2_Cancer: Getting informed about the Basics. –Chapter 3_Tumour Biology: An Introduction. –Chapter 4_Role of Angiogenesis in Tumour–Chapter 5_Biology, Chemistry and Physics of Cancer Cell Motility and Metastasis. –Chapter 6_MRI, CT, and PETSCAN: An Engineer’s Perspective. –Chapter 7_Diffusion, MRI, and Cancer Diagnosis: Physicists’ Outlook. –Chapter 8_Oncology: Radiation Oncologist’s View. –Chapter 9_Radiomics: Comprehensive and Advance Image Analysis based Radiological Investigations. –Chapter 10_Oncology: Biochemists’ Perspective. –Chapter 11_Oncology: Pathologist’s View. –Chapter 12_Surgical Oncology: An Overview. –Chapter 13_Medical Oncology in Cancer Treatment. - Chapter 14_Effects of Cancer Chemotherapy on Immune System. –Chapter 15_Side-effects of Cancer Chemotherapy. –Chapter 16_Telomerase and its Therapeutic Implication in Cancer. –Chapter 17_Pain Management in Oncology. –Chapter 18_Other Approaches in Cancer Research: Stem-cell Research, Translational Research, and Immuno-therapy. –Chapter 19_Cancer Cell Lines: It’s Implication in Therapeutics. –Chapter 20_ Genomics of Cancer. –Chapter 21_Diabetes and Cancer Link. –Chapter 22_Cancer Genomics and Diagnostics: Northeast Indian Scenario. –Chapter 23_Oncology Informatics, AI and Drug Discovery. –Chapter 24_Statistics in Cancer: Diagnosis, Disease Progression, Treatment Efficacy and Patient Survival Studies. –Chapter 25_Epidemiology of Cancer: Asian Perspective.

    Out of stock

    £999.99

  • Methods of Mathematical Oncology: Fusion of

    Springer Verlag, Singapore Methods of Mathematical Oncology: Fusion of

    1 in stock

    Book SynopsisThis book presents original papers reflecting topics featured at the international symposium entitled “Fusion of Mathematics and Biology” and organized by the editor of the book. The symposium, held in October 2020 at Osaka University in Japan, was the core event for the final year of the research project entitled “Establishing International Research Networks of Mathematical Oncology.” The project had been carried out since April 2015 as part of the Core-to-Core Program of Japan Society for the Promotion of Science (JSPS). In this book, the editor presents collaborative research from prestigious organizations in France, the UK, and the USA. By utilizing their individual strengths and realizing the fusion of life science and mathematical science, the project achieved a combination of mathematical analysis, verification by biomedical experiments, and statistical analysis of chemical databases.Mathematics is sometimes regarded as a universal language. It is a valuable property that everyone can understand beyond the boundaries of culture, religion, and language. This unifying force of mathematics also applies to the various fields of science. Mathematical oncology has two aspects, i.e., data science and mathematical modeling, and definitely helps in the prediction and control of biological phenomena observed in cancer evolution.The topics addressed in this book represent several methods of applying mathematical modeling to scientific problems in the natural sciences. Furthermore, novel reviews are included that may motivate many mathematicians to become interested in biological research.Table of ContentsPART 1: Mathematical Modeling: D. Guan, X. Luo, and H. Gao, Constitutive Modelling of Soft Biological Tissue from Ex Vivo to In Vivo: Myocardium as an Example.- T. Colin, T. Michel, and C. Poignard, Mathematical Modeling of Gastro-intestinal Metastasis Resistance to Tyrosine Kinase Inhibitors.- Y. Tanaka and T. Yasugi, Mathematical Modeling and Experimental Verification of the Proneural Wave.- D. Kumakura and S. Nakaoka, Exploring Similarity between Embedding Dimension of Time-series Data and Flows of an Ecological Population Model.- T. Hayashi, Mathematical Modeling for Angiogenesis.- S. Collin, Corridore and C. Poignard, Floating Potential Boundary Condition in Smooth Domains in an Electroporation Context.- N. L. Othman and T. Suzuki, Free Boundary Problem of Cell Deformation and Invasion.- L. Preziosi and M. Scianna, Multi-level Mathematical Models for Cell Migration in Confined Environments.- S. Magi, Mathematical Modeling of Cancer Signaling Addressing Tumor Heterogeneity.- N. Sfakianakis and Mark A.J. Chaplain, Mathematical Modelling of Cancer Invasion: A Review.- T. Williams, A. Wilson, and N. Sfakianakis, The First Step towards the Mathematical Understanding of the Role of Matrix Metalloproteinase-8 in Cancer Invasion.- PART II: Biological Prediction: T. Ito, T. Suzuki, and Y. Murakami, Mathematical Modeling of the Dimerization of EGFR and ErbB3 in Lung Adenocarcinoma.- H. Kubota, Selective Regulation of the Insulin-Akt Pathway by Simultaneous Processing of Blood Insulin Pattern in the Liver.- D. Oikawa, N. Hatanaka, T. Suzuki, and F. Tokunaga, Mathematical Simulation of Linear Ubiquitination in T Cell Receptor-mediated NF-κB Activation Pathway.- Y. Ito, D. Minerva, S. Tasaki, M. Yoshida, T. Suzuki, and A. Goto, Time Changes in the VEGF-A Concentration Gradient Lead Neovasculature to Engage in Stair-like Growth.- N. Hatanaka, M. Futakuchi, and T. Suzuki, Mathematical Modeling of Tumor Malignancy in Bone Microenvironment.- M. Yamamoto and Jun-ichiro Inoue, Signaling Networks Involved in the Malignant Transformation of Breast Cancer.- PART III: Data Science: R. Morishita, H. Takahashi, and T. Sawasaki, Cell-free Based Protein Array Technology.- Y. Nojima and Y. Takeda, Omics Data Analysis Tools for Biomarker Discovery and the Tutorial.- M. Oyama and H. Kozuka-Hata, Integrative Network Analysis of Cancer Cell Signaling by High-resolution Proteomics.- N. Nakamura and R. Yamada, Distance-matrix-based Extraction of Motility Features from Functionally Heterogeneous Cell Populations.- S. Kawasaki, H. Hayashi, and Y. Tominaga, Data Analytic Study of Genetic Mechanism of Ovarian Carcinoma from Single Cell RNA-seq Data.

    1 in stock

    £143.99

  • Immuno-Oncology Crosstalk and Metabolism

    Springer Verlag, Singapore Immuno-Oncology Crosstalk and Metabolism

    1 in stock

    Book SynopsisThis book discusses the novel metabolic cross-talk between immune and tumor cells in the tumor microenvironment that promotes their growth and progression. It also describes deregulated metabolism in cancer cells that promotes suppressive and cancer cell-favourable microenvironment. Further, the book provides novel insights on the metabolic changes in immune cells that promote tumor cell growth and survival. In turn, it also reviews the involvement of immuno-onco metabolic cross-talk in the development of resistance to chemo-radiation therapy (CRT) in tumor cells. Lastly, it also explores the potential of immuno-oncology metabolism as a therapeutic approach against tumor cells.Table of Contents1 Cancer Metabolism and Aggressive Tumor Behaviour.- 2 Immune Cell Metabolism and Function.- 3 Cancer Cell Metabolism Effecting Immune function.- 4 Immune Cell Metabolites as Fuel for Cancer Cells.- 5 Immuno-Onco metabolism and Resistance to Therapy.- 6 Targeting Immuno-Onco metaolism in Cancers.- 7 Timing of the major metabolic switches in immune cell activation and differentiation during cancer development.

    1 in stock

    £125.99

  • Cancer in the Arab World

    Springer Verlag, Singapore Cancer in the Arab World

    Out of stock

    Book SynopsisThis is an Open Access book. This book is a must-have for healthcare providers and researchers, public health specialists and policy makers who are interested and involved in cancer care in the Arab world. The Arab world consists of 22 countries, which are members of the Arab League and spanning over 13,132,327 km2 with over 423,000,000 population. Over the past few decades, the Arab world has witnessed a swift evolution in healthcare provision. Nonetheless, Arab countries have considerable variability in economic capabilities, resource allocation, and intellectual talent that inevitably reflect on access to modern cancer care and prevention. This book is authored by experts from the Arab world who provide vital information on cancer statistics and risk factors, available clinical care pathways and infrastructure, and prevention programs in their individual countries. The chapters also address specific challenges in each country and insights into future directions to achieve optimal care with conventional and novel diagnostics and therapies to keep up with the era of precision medicine. Special topics of interest and unique to the Arab world are also discussed, such as out of the country’s medical tourism for cancer care and cancer care during war and conflict. Other special chapters include: Cancer research in the Arab world, Radiation therapy in Arab World and Pediatric Oncology in the Arab World Cancer in the Arab World is the first comprehensive book that addresses cancer care in depth in all Arab countries and it is endorsed by the prestigious Emirates Oncology Society.Table of Contents 1 Introduction 2 General Oncology Care in Algeria 3 General Oncology Care in Bahrain 4 General Oncology Care in Egypt 5 General Oncology Care in Iraq 6 General Oncology Care in Jordan 7 General Oncology Care in Kuwait 8 General Oncology Care in Lebanon 9 General Oncology Care in Libya 10 General Oncology Care in Mauritania 11 General Oncology Care in Morocco 12 General Oncology Care in Oman 13 General Oncology Care in Palestine 14 General Oncology Care in the Kingdom of Saudi Arabia 15 General Oncology Care in Somalia 16 General Oncology Care in Sudan 17 General Oncology Care in Syria 18 General Oncology Care in Tunisia 19 General oncology care in the UAE 20 General Oncology Care in the Republic of Yemen 21 General Oncology Care in Qatar, Comoros & Djibouti 22 Breast Cancer in the Arab World 23 Colorectal Cancer in the Arab World 24 Palliative Care in the Arab World 25 Cancer Research in the Arab World 26 Pediatric Oncology in the Arab World 27 Challenges Associated with Medical Travel for Cancer Patients in the Arab World: A Systematic Review 28 Radiation Therapy in Arab World 29 Cancer Care During War and Conflict

    Out of stock

    £999.99

  • Role of MicroRNAs in Cancers

    Springer Verlag, Singapore Role of MicroRNAs in Cancers

    3 in stock

    Book SynopsisThis book discusses the potential roles of miRNA as a crucial regulator in cancer biology. It examines the regulation of drug resistance by miRNAs in cancers and the mechanism of their deregulated expression. The book discusses the role and molecular mechanism of miRNA in regulating cellular proliferation and cell cycle. It analyses circulating miRNAs as biomarkers for cancer diagnosis and prognosis. It also analyzes the role of miRNA as a modulator of the development and function of tumor-associated immune cells. It explores the cross-talk between miRNA and reactive oxygen species (ROS) in pathogenesis, cancer therapeutic tolerance, and resistance. It provides insights into the role of miRNA in cancer angiogenesis, metastasis and describes strategies and associated challenges of miRNA-based therapies.Table of ContentsChapter 1. Introduction to microRNAs and cancers.- Chapter 2. microRNAs and cancer signaling pathways.- Chapter 3. Role of microRNAs in cell growth proliferation and tumorigenesis.- Chapter 4. Impact of microRNAs in cell adhesion and tumor angiogenesis.- Chapter 5. Modulation of oxidative stress by microRNAs in cancers.- Chapter 6. microRNAs targeting tumor microenvironment and immune modulation.- Chapter 7. Circulating miRNA in prognosis, diagnosis and their role in controlling the fate of cancer stem cells.- Chapter 8. The role of miRNAs in the regulation of drug resistance among different cancers.- Chapter 9. The mechanisms of miRNA deregulation in cancer outbreak.- Chapter 10. Bioinformatic profiling of miRNAs in Cancers.

    3 in stock

    £132.99

  • Hormone Related Cancer Mechanistic and

    Springer Verlag, Singapore Hormone Related Cancer Mechanistic and

    Out of stock

    Book SynopsisThe nanotheranostics sector provides a very promising strategy for monitoring drug biodistribution and pathology longitudinal processes by integrating the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membrane with carrying drugs, nanomaterials have been used for various biomedical applications. This book covers the progress made in hormone-related cancer and their management by nonmedicinal therapy for targeting the hormone regulated cancer with their clinical progress and clinical hurdles.Table of ContentsChapter 1. Conventional Treatment Approaches in Hormonal Cancer Treatment and Challenges.- Chapter 2. Concept of Nanomedicine in Endocrine Hormone Cancer Treatment.- Chapter 3. Progress of Cancer Nanomedicine, Clinical Hurdles and Opportunities.- Chapter 4. Emergence of Nanohybrids in Hormonal Cancer Targeted Therapy.- Chapter 5. Conventional to Nanoscale-Based Carrier System in Management of Ovarian Cancer.- Chapter 6. Pancreatic Cancer Nanoparticles Targeted Therapy via Epidermal Growth Factor Receptor.- Chapter 7. Nanocarriers Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead.- Chapter 8. Pancreatic Cancer Treatment by Using of Theranostics Nanoparticles.- Chapter 9. Nanomedicine Based Combinational Therapy for Breast Cancer.- Chapter 10. Nano-Liposomal System for Breast Cancer Therapy.- Chapter 11. Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer.- Chapter 12. Effect of Thymoquinone and Its Delivery Through Using of Nanomedicine in Benign Prostatic Hyperplasia.- Chapter 13. Concept of Nanotechnology in Management of Neuroendocrine Tumours.- Chapter 14. Neurocognitive Underpinning of Neurological Disorders: The Role of Default Mode Network.- Chapter 15. Neuroendocrine Carcinoma of The Endometrium: Conventional Treatment Approach to Nanomedicine.- Chapter 16. Effective Luteinizing Hormone Drug Delivery by Gold Nanoparticles in Hormonal Cancer Treatment.- Chapter 17. Regulatory Landscapes in Approval of Cancer Vaccines.

    Out of stock

    £999.99

  • Physical Therapy and Research in Patients with

    Springer Verlag, Singapore Physical Therapy and Research in Patients with

    Out of stock

    Book SynopsisThis collection of chapters describes in detail the physical therapy research in patients with various types of cancers to help medical professionals and physical therapists help improve the physical function, activity of daily living, quality of life, the survival rate in cancer patients and cancer survivors. It provides not only information on rehabilitation but details on physical therapy cancer research and research methods. The book provides practical skills to treat the patients and to create useful and effective physical therapy programs by giving step-by-step tutorials to help readers learn various techniques. Along with presenting an introduction to physical therapy of cance and new findings, the authors provide recommendations on each cancer therapy. Physical Therapy and Research in Patients with Cancer is aimed at physical therapists and student physical therapists. Undergraduate and postgraduate students also can use our book to understand the basics and get up-to-date information. By sharing the latest research with our readers, the book creates a foundation for further development in this field of study. Table of ContentsPart 1 Physical Function and Health Related Quality of Life Chapter 1 Physical function and health related QOL in cancer survivors Chapter 2 Physical function and health-related quality of life after breast cancer surgery Chapter 3 Physical function and health-related quality of life in patients with gastrointestinal cancer Chapter 4 Physical function and health related QOL in surgically treated patients with malignant pleural mesothelioma Chapter 5 Muscle mass, cachexia, and health-related quality of life in patients with hematologic malignancies Chapter 6 Exercise capacity and health-related quality of life in patients after lung resection for non-small cell lung cancer Part 2 Physical Exercise Chapter 7 Effect of physical exercise on physical function and survival rate in cancer patients Chapter 8 Exercise therapy on muscle mass and physical function in patients undergoing allogeneic hematopoietic stem cell transplantation Chapter 9 Physical exercise and immune function in patients with hematological malignancies Chapter 10 Exercise protocols for counteracting cancer cachexia-related declines in muscle mass and strength and the clinical assessment of skeletal muscle Chapter 11 Physical Exercise and Skeletal Muscle Adaptation in Cancer Cachexia Chapter 12 Physical function and physical activity in patients with advanced lung cancer Chapter 13 Physical Activity in Patients with Breast Cancer Part 3 Physical Function and Other Symptom Chapter 14 Multiple frailty in elderly patients with cancer Chapter 15 Postoperative complications in patients with esophageal cancer Chapter 16 Cancer-related lymphedema and obesity Chapter 17 Cancer-related pain and effects of non-pharmacologic intervention Chapter 18 Nutrition and daily activities in older patients after gastrectomy Chapter 19 Frailty and mental health in older patients with gastrointestinal cancer Chapter 20 Physical function and nutrition in patients with hematological malignancies Chapter 21 Physical Function and Nutrition in Patients with Esophageal Cancer and Head and Neck Cancer Part 4 Skeletal Muscle Chapter 22 Skeletal muscle oxygenation in patients with malignant hematopoietic disease Chapter 23 Sarcopenia and physical performance in patients with cancer Chapter 24 Cachexia and postoperative outcomes in elderly patients with gastrointestinal cancer Chapter 25 Mechanism of skeletal muscle atrophy using a mice cancer cachexia model.

    Out of stock

    £999.99

  • The MicroRNA Quantum Code Book

    Springer Verlag, Singapore The MicroRNA Quantum Code Book

    Out of stock

    Book SynopsisThis book tells the story of the discovery of microRNA (miRNA) quantum code, the basic theory of biological data science for medical investigation with miRNA, to its implementation. It explains the use of a new algorithm called the miRNA entangling target sorter (METS), based on the quantum computation algorithm, to give the etiologic analysis for diseases such as cancer, infectious diseases, and age-related disorders. Providing detailed descriptions to make the METS algorithm simple to grasp, it also explains the accumulated cutting-edged data for human diseases utilizing artificial intelligence (AI) for quantum miRNA language (miRNA qubit) (MIRAI). Further, it describes a discovery story for quantum miRNA surveillance against tumors and quantum miRNA immunity against viruses. Since this is a multidisciplinary field of study, crucial details on physics, mathematics, computer science, data science, virology, immunology, oncology, pathology, and biology are supplied.This book will support professional advancement for scientists, clinicians, educators, students, and science enthusiasts. The reader's knowledge of the subject and its practical medical applications will be enriched by the wealth of informative figures and supporting data.Table of ContentsRNA Controls RNA.- MicroRNA Qubit.- Matrix Multiplication for MicroRNA Qubit.- MicroRNA Quantum Computing.- Vital METS/MIRAI.- Etiologic Analysis for Human cancer.- Encounter with the unknown.- Diabetes Mellitus: Quantum microRNA Language with Artificial Intelligence (MIRAI) as an Early Diagnostic Tool for Type II Diabetes Mellitus for Sustainable Healthcare.- Thyroid Cancer: Quantum microRNA Language/Artificial Intelligence (MIRAI)-Based Etiologic Analysis of Thyroid Cancer by Serum/Plasma miRNA Panel Data.- Metabolic Disease and Alzheimer’s Disease.- Quantum MiRNA Immunity and Quantum MiRNA Surveillance.- Quantum MiRNA code.

    Out of stock

    £999.99

  • Therapeutic potential of Cell Cycle Kinases in

    Springer Verlag, Singapore Therapeutic potential of Cell Cycle Kinases in

    Out of stock

    Book SynopsisThis book highlights the interrelation between cell cycle regulators and breast cancer phenotypes. It reviews the roles of Cyclin-Dependent Kinases (CDK) in driving cell cycle progression, cell cycle checkpoints and dysregulation in breast cancer. It also examines the prognostic significance of CDKs in breast cancer. and CDK inhibitors for the treatment of metastatic breast cancer. Further, the book discusses the role of different G1 cyclins in differentiation, chromosome stability, and transcriptional regulation in breast cancer. Additionally, it examines the role of immunogenic effects of CDK inhibitors, the mechanism of resistance and the current clinical trials in breast cancer treatment. Towards the end, the book explores cell cycle regulation as an attractive target for targeted drug therapy in breast cancer. This book is a comprehensive yet concise resource for oncologists and researchers interested in exploring the therapeutic potential of Cyclin-Dependent Kinases in breast cancer. ​Table of ContentsChapter 1 An introduction to breast cancer.- Chapter 2 Current treatment approaches to breast cancer. Chapter 3 Introduction to cell cycle and its regulators.- Chapter 4 Cell cycle and cancer.- Chapter 5 cell cycle dysregulation in breast cancer.- Chapter 6 Molecular Subtypes of breast cancer and CDK dysregulation.- Chapter 7 Breast tumor micro environment and CDks.- Chapter 8 CDK Dysregulation in Breast Cancer: A Bioinformatics Analysis.- Chapter 9 CDK1 Dysregulation in Breast Cancer.- Chapter 10 CDK4/CDK6 dysregulation in estrogen positive receptor breast cancers.- Chapter 11 Therapeutic implications of CDKs in Breast Cancer.- Chapter 12 Novel CDK Inhibitors in Breast Cancer.- Chapter 13 Targeting CDKs with other chemotherapeutic drugs- A combinatorial approach.- Chapter 14 CDKs in cell-cycle progression and therapeutic strategies in Human breast cancer.- Chapter 15 CDk inhibitor for treatment of breast cancer.- Chapter 16 Response of therapy in cell cycle regulatory genes in breast cancer.- Chapter 17 Different cyclins and their significance in Breast cancer.

    Out of stock

    £999.99

  • Pan Stanford Publishing Pte Ltd Handbook of Therapeutic Biomarkers in Cancer

    Out of stock

    Book SynopsisIn this volume, a team of internationally recognized experts provide an in-depth description of therapeutic biomarkers across a broad area of cancer research and oncology. With a wealth of information to specific therapies, each chapter focuses on a class of targeted chemotherapy agents. The book describes established and evolving diagnostic tests for therapeutic biomarkers that predict benefit, response, resistance, or drug side effects from specific therapeutic interventions. This volume is an essential handbook for health professionals and scientists researching current applicable biomarkers in oncology.Table of ContentsOverview: Therapeutic Biomarkers in Cancer. Statistical Considerations in the Development and Evaluation of Therapeutic Biomarkers in Cancer. Role of Biomarkers in Clinical Development of New Cancer Therapies. HER2 as a Prognostic and Predictive Biomarker in Cancer. Hormone Receptors and Endocrine Therapy in Breast Cancer. Predictive Biomarkers for Epidermal Growth Factor Receptor (EGFR) Agents in Non-Small Cell Lung Cancer. Markers of Sensitivity and Resistance to EGFR Inhibitors in Colorectal Cancer. Targeting BCR-ABL for Molecular Therapy of Chronic Myelogenous Leukemia. Gastrointestinal Stromal Tumors (GISTs): From Molecular Pathogenesis to Therapy. PML/RARa Fusion Gene and Response to Retinoic Acid and Arsenic Trioxide Treatment. Dihydropyrimidine Dehydrogenase Deficiency and 5-Fluouracil Toxicity. UGT1A1 Polymorphisms and Mutations Lead to Irinotecan-Induced Toxicity. The 21-Gene Recurrence Score and Benefit of Chemotherapy in Estrogen Receptor-Positive Breast Cancer. MammaPrint for Individualized Recurrence Risk Assessment and Treatment Recommendations for Early-Stage Breast Cancer Patients. BRCA mutation and PARP Inhibitors. EML4-ALK Fusion Gene and Therapy with ALK-targeted Agents in Non-Small Cell Lung Cancer. BRAF-Targeted Therapy in Metastatic Melanoma.

    Out of stock

    £126.00

  • Gynaecologic Cancer: A Handbook for Students and

    Pan Stanford Publishing Pte Ltd Gynaecologic Cancer: A Handbook for Students and

    5 in stock

    Book SynopsisGynaecologic oncology is one of the most important subjects in gynaecology and a very challenging field. The management of patients with gynaecological cancers is complex, as the impact of the outcome of such cancers can be critical. This handbook covers the basics of carcinogenesis and the advances in the prevention and management of all gynaecologic cancers, including breast cancer. Gynaecologic oncology has always been perceived as the most difficult subject in obstetrics and gynaecology, but this handbook proves it otherwise. The text is presented in a systematic and easy-to-understand manner and is supplemented by plenty of images and illustrations and up-to-date references from established sources. The book also introduces readers to the new FIGO 2009 staging system and will be a very useful reference for researchers and clinicians.Trade Review"This comprehensive handbook covers the essentials of gynaecological oncology. The text includes all pelvic tumours as well as breast cancer, cancer in pregnancy, and fertility-sparing possibilities. It outlines well the complications of treatment with the basics of radiotherapy and chemotherapy. This is a good book for the aspiring junior doctor to have as a guide for current clinical practice and to review before ‘that exam’. A well-worth buy!"Prof. John H. Shepherd, Royal Marsden Hospital, UK"This book presents a comprehensive collection of information on gynaecologic oncology in a systematic and easy-to-understand manner. I am convinced that students, young gynaecologists, and gynaecologic oncologists will enjoy reading this informative text."Dr. Shingo Fujii, Kitano Hospital, JapanTable of ContentsWorld Cancer Statistics and Burden of Gynae Cancer. Genes and Carcinogenesis. Cancer of Vulva. Cancer of Vagina. Screening for Cervical Cancer. Human Papillomavirus and HPV Vaccine. Management of Pre-invasive Disease of Cervix. Cancer of Cervix. Cancer of Endometrium. Uterine Sarcoma. Cancer of Fallopian tube. Cancer of Ovary (Epithelial). Ovarian Germ Cell Tumours. Ovarian Sex Cord Stromal Tumours. Gestational Trophoblastic Disease. Breast Cancer for Gynaecologic Oncologist. Gynaecologic Cancer in Pregnancy. Tumour Markers in Gynaecologic Oncology. Diagnostic Imaging in Gynaecologic Oncology. Peri-operative Care for Gynaecologic Cancer Patients. Basic Anatomy and Principles of Surgery in Gynae Oncology. Basic Principles of Radiotherapy. Basic Principles of Chemotherapy. Modulating Agents,Response Modifier and Targeted Therapy. Immunotherapy and Hormonal Therapy. Management of Long-term Side Effects of Gynae Cancer Treatment. Nutritional Support For Gynaecologic Cancer Patients. Basic Surgical Procedures in Gynaecologic Oncology. Laparoscopic and Robotic Surgery in Gynaecologic Cancers. Index.

    5 in stock

    £180.50

  • Practical Inverse Problems and Their Prospects:

    Springer Verlag, Singapore Practical Inverse Problems and Their Prospects:

    1 in stock

    Book SynopsisThis book comprises select proceedings of the workshop “Practical inverse problems and their prospects” held online by zoom, from Mar 2nd to Mar. 4th, 2022, supported by Institute of Mathematics for Industry, Kyushu University focusing on cutting-edge research carried out in the areas of practical inverse problems based on industry-academia and interdisciplinary collaborations.Various themes on practical inverse problems covered in this book are medical imaging, non-destructive and non-invasive inspections, viscoelastic waves, remote sensing, infrared light tomography, maintenance of infrastructure, and so on, and mathematical theories in inverse problems are also handled in these proceedings.All papers in this book are written by qualified authors in the practical inverse problems area and also the papers are newly announced. Readers can get leading-edge information on practical inverse problems.Table of Contents

    1 in stock

    £170.99

  • Molecular Biomarkers for Cancer Diagnosis and

    Springer Molecular Biomarkers for Cancer Diagnosis and

    1 in stock

    Book SynopsisChapter 1. Molecular Biomarkers of Cancer and their Diagnostic Applications.- Chapter 2. Statistical Models in Cancer Management.- Chapter 3. Deep Learning Techniques for Computer Aided Diagnosis of Various Cancers.- Chapter 4. Machine Learning Techniques in Computer Aided Diagnosis for Effective Detection of Malignant Tissues.- Chapter 5. Molecular Mechanisms of Oncogenesis.- Chapter 6. Application of CRISPR in Cancer Research and Treatment.- Chapter 7. Nanobiosensing Platforms for Early Detection of Cancer.- Chapter 8. Bionanotechnological Strategies and Tools for Cancer Prediction, Prevention and Therapy.- Chapter 9. Central Nervous System Tumors.- Chapter 10. Biomedical Approaches in the Research and Management of Head and Neck Squamous Cell Carcinoma.- Chapter 11. Applications of Molecular Biology and Biomedical Advances in Ocular Oncology.- Chapter 12. Molecular Markers in Oral Cancer.- Chapter 13. MicroRNAs as Tools for Early Diagnosis and Predicting Response to Therapy in Oe

    1 in stock

    £197.99

  • Tata Memorial Center Textbook of Oncology

    Springer Verlag, Singapore Tata Memorial Center Textbook of Oncology

    3 in stock

    Book SynopsisWritten by experts from the globally renowned Tata Memorial Centre (TMC) in Mumbai, this book provides a crisp and highly distilled review of clinical aspects of oncology, primarily for postgraduate students and fellows. TMC Textbook of Oncology covers the basic principles of oncology, solid tumors, hematologic cancers, and special topics such as oncological emergencies, pain management, intensive care, and the impact of comorbidities. Chapters have been structured uniformly covering epidemiology, clinical presentation and evaluation, principles of multidisciplinary management and stage-wise management and prognosis. Each chapter has been further extensively reviewed by an eminent national or international expert.This textbook is an extension of the annual Evidence Based Meetings that TMC has conducted since 2002, wherein experts have distilled the evidence for diagnostic and therapeutic strategies in oncology not only on strength of evidence but also on applicability in a variety of settings. The Textbook will provide the reader with a glimpse into the clinical decision-making process at TMC, which is an institution that provides cancer care to all sections of the society.An essential read for all students and practitioners in this field as a reference as well as practical aid in clinical decision making. Table of ContentsPart I. Basic Principles.- Chapter 1. Basic and Translational Science in Oncology.- Chapter 2. Principles of Surgical Oncology.- Chapter 3. Radiation Oncology.- Chapter 4. Principles of Systemic Treatment of Cancer.- Chapter 5. General Overview of Pediatric Oncology: Epidemiology and Challenges in Childhood.- Chapter 6. Principles of Oncopathology.- Chapter 7. Oncologic Hematopathology.- Chapter 8. Microbiology in Oncology.- Chapter 9. Principles of Imaging in Oncology.- Chapter 10. Nuclear Medicine in Oncology.- Chapter 11. Interventional Radiology in Oncology.- Chapter 12. Anaesthesia in Oncology.- Chapter 13. Transfusion Medicine in Oncology.- Chapter 14. Palliative Care in Oncology.- Chapter 15. Clinical Pharmacology in Oncology.- Chapter 16. Cancer Staging.- Part II. Public Health.- Chapter 17. Cancer Registration in India: A Tool to Estimate Incidence and Mortality.- Chapter 18. Cancer Screening in India.- Part III. Hematological Malignancies.- Chapter 19. Adult Lymphoblastic Leukemias.- Chapter 20. Adult Lymphomas.- Chapter 21. Adult Myeloproliferative Disorders/ Myelodysplastic Syndromes/Overlap Syndromes.- Chapter 22. Plasma Cell Dyscrasia.- Chapter 23. Immunodeficiency-associated Lymphoproliferative Disorders.- Chapter 24. Histiocytic and Dendritic Cell Neoplasms.- Chapter 25. Pediatric Acute Leukemias.- Chapter 26. Pediatric Hodgkin Lymphoma.- Chapter 27. Pediatric Myeloproliferative Disorders /Myelodysplastic Syndromes/Overlap Syndromes.- Chapter 28. Hematopoietic Stem Cell Transplantation.- Part IV. Solid Tumors.- Chapter 29. Central Nervous System (CNS) Tumours.- Chapter 30. Head and Neck Cancers.- Chapter 31. Thyroid and Parathyroid Cancer.- Chapter 32. Management of Breast Cancer.- Chapter 33. Non-Small Cell Lung Cancer.- Chapter 34. Small Cell Lung Cancer (SCLC).- Chapter 35. Mediastinal Tumours.- Chapter 36. Esophageal Cancer.- Chapter 37. Biliary Tract Cancer.- Chapter 38. Liver Cancer.- Chapter 39. Gastric Cancer.- Chapter 40. Colon Cancer.- Chapter 41. Small Intestine Cancer.- Chapter 42. Anal Canal Cancer.- Chapter 43. Pancreatic Cancer.- Chapter 44. Gastrointestinal Stromal Tumor.- Chapter 45. Gastroentero-pancreatic Neuroendocrine Tumours.- Chapter 46. Rectal Cancer.- Chapter 47. Renal Cancer.- Chapter 48. Adrenal Cancer.- Chapter 49. Urinary Bladder Cancer.- Chapter 50. Upper Tract Urothelial Cancer.- Chapter 51. Prostate Cancer.- Chapter 52. Penile Cancer.- Chapter 53.Testicular Cancer.- Chapter 54. Uterine Cancer.- Chapter 55. Cervical Cancer.- Chapter 56. Vulva and Vaginal Cancers.- Chapter 57. Gestational Trophoblastic Disease.- Chapter 58. Epithelial Ovarian Cancer.- Chapter 59. Non-Epithelial Ovarian Cancer.- Chapter 60. Bone Sarcomas.- Chapter 61. Soft Tissue Sarcoma: Principles of Management.- Chapter 62. Ewing Sarcoma.- Chapter 63. Wilms Tumor.- Chapter 64. Neuroblastoma.- Chapter 65. Retinoblastoma.- Chapter 66. Rare Pediatric Tumors.- Chapter 67. Childhood and Adolescent Extracranial Germ Cell Tumors.- Chapter 68. Hepatoblastoma.- Part V. Special Topics.- Chapter 69. Oncological Emergencies.- Chapter 70. Pain Management in Oncology.- Chapter 71. Intensive Care in Oncology.- Chapter 72. Vascular Access in Oncology.- Chapter 73. Comorbidities in the Cancer Patient.- Chapter 74. Hereditary Cancers: Genetic Counselling, Genetic Testing and Risk Management.- Chapter 75. Library and Information Needs in Oncology: In Pursuit of Information.- Chapter 76. Oncology Training and Education in India: The Tata Memorial Centre (TMC) Perspective.

    3 in stock

    £161.99

  • Recent Topics on Prevention Diagnosis and

    Springer Verlag, Singapore Recent Topics on Prevention Diagnosis and

    1 in stock

    Book SynopsisThis book provides a practical overview of a central topic in cervical cancer concerning human papillomavirus (HPV), prevention, cervical cancer screening, diagnosis, and treatment.

    1 in stock

    £107.99

  • Amazon Digital Services LLC - Kdp Fuck you Brustkrebs

    15 in stock

    Book Synopsis

    15 in stock

    £14.37

  • Amazon Digital Services LLC - Kdp Prostate Cancer

    15 in stock

    Book Synopsis

    15 in stock

    £14.29

  • Amazon Digital Services LLC - Kdp Complete Pancreatic Cancer Cookbook

    15 in stock

    Book Synopsis

    15 in stock

    £11.92

  • Amazon Digital Services LLC - Kdp Natural Remedies and Cure for Cancer

    15 in stock

    Book Synopsis

    15 in stock

    £12.09

  • Independently Published Ill Have a Double

    15 in stock

    Book Synopsis

    15 in stock

    £18.46

  • Independently Published Surviving Chronic Illness and palliative care

    15 in stock

    Book Synopsis

    15 in stock

    £14.33

  • Amazon Digital Services LLC - Kdp The Benefits And Risks Of Using Apricot Seeds For

    15 in stock

    Book Synopsis

    15 in stock

    £11.66

  • Independently Published Understanding Pituitary Tumors

    15 in stock

    Book Synopsis

    15 in stock

    £13.62

  • Amazon Digital Services LLC - Kdp Understanding Chronic Myeloid Leukemia

    15 in stock

    Book Synopsis

    15 in stock

    £13.02

  • Independently Published The Cancer Blueprint: A groundbreaking and

    15 in stock

    Book Synopsis

    15 in stock

    £10.02

  • Independently Published Plant-Powered Cancer-Fighting Recipes: Delicious

    15 in stock

    Book Synopsis

    15 in stock

    £46.21

  • Independently Published From Diagnosis to Remission: A Patient's Guide to

    15 in stock

    Book Synopsis

    15 in stock

    £11.10

  • Independently Published Living with Colon Cancer: A Personal Journey of

    15 in stock

    Book Synopsis

    15 in stock

    £11.41

  • Independently Published Colon Cancer and Mental Health: Coping Strategies

    15 in stock

    Book Synopsis

    15 in stock

    £12.12

  • Amazon Digital Services LLC - Kdp Colección Joeys Hat

    15 in stock

    Book Synopsis

    15 in stock

    £13.45

  • I Am Not My Breast Cancer

    HarperCollins Publishers Inc I Am Not My Breast Cancer

    Out of stock

    Book SynopsisI am not my breast, and I am not cancer; they are only pieces of who I am. What is my heart like, am I kind, strong, loving, compassionate. . . . Those are the things that count.I Am Not My Breast Cancer gathers the warm, loving, frank, and informed voices of more than 800 women—from every state in the nation and from continents as far away as Australia and Africa—who reveal their fears, trade advice, share experiences, and express their deepest, most intimate concerns. Nothing before this groundbreaking book has captured the real experience of breast cancer. It is essential reading for any woman with this diagnosis.I Am Not My Breast Cancer offers women the companionship of other women dealing with this disease. Ruth Peltason, who has twice undergone treatment for breast cancer, has woven their stories together while maintaining the authenticity of their voices. These are ordinary women dealing with this cancer an

    Out of stock

    £999.99

  • The Cancer Code A Revolutionary New Understanding

    HarperCollins Publishers Inc The Cancer Code A Revolutionary New Understanding

    Out of stock

    Book Synopsis

    Out of stock

    £999.99

  • Sit Stay Heal

    HarperCollins Publishers Inc Sit Stay Heal

    Out of stock

    Book Synopsis“Written with grace and emotional honesty, Sit, Stay, Heal will live with you long after the last page.”— John Grogan, bestselling author of Marley & MeFor more than two decades, esteemed veterinary oncologist Dr. Renee Alsarraf treated cancer in her beloved canine patients. Then, at age fifty-one, she was diagnosed with cancer herself.Sit, Stay, Heal: What Dogs Can Teach Us About Living Well is Dr. Renee’s unforgettable testament to the extraordinary healing nature of dogs. Every day in her veterinary practice, she bears witness to the undeniable bond between pets and their people. However, while we are busy teaching them to “sit” and “stay,” they have their own, more profound, lessons to impart. In Sit, Stay, Heal, we meet Cosmo, the golden retriever who arrives at Renee’s office just before his fourt

    Out of stock

    £999.99

  • A Cancer In The Family Take Control of Your

    Penguin Putnam Inc A Cancer In The Family Take Control of Your

    Out of stock

    Book SynopsisA Kirkus Best Book of 2016 Oncologist and cancer gene hunter Theo Ross delivers the first authoritative, go-to for people facing a genetic predisposition for cancer   There are 13 million people with cancer in the United States, and it’s estimated that about 1.3 million of these cases are hereditary. Yet despite advanced training in cancer genetics and years of practicing medicine, Dr. Theo Ross was never certain whether the history of cancers in her family was simple bad luck or a sign that they were carriers of a cancer-causing genetic mutation. Then she was diagnosed with melanoma, and for someone with a dark complexion, melanoma made no sense. It turned out there was a genetic factor at work.   Using her own family’s story, the latest science of cancer genetics, and her experience as a practicing physician, Ross shows readers how to spot the patterns of inherited cancer, how to get tested for cancer-causing gen

    Out of stock

    £999.99

  • Oxford University Press Inc Memory and Attention Adaptation Training A Brief

    Out of stock

    Book SynopsisCancer-related cognitive impairment (CRCI) may affect nearly half of all cancer survivors and can persist for years after completing cancer treatment. Memory and Attention Adaptation Training (MAAT) is a cognitive-behavioral therapy offering evidence-based, nonpharmacological treatment of this common survivorship condition. Organized into a session-by-session Clinician Manual and related Survivor Workbook, MAAT is conducted in eight treatment visits and has been demonstrated effective when delivered through telehealth technology, so survivors can readily fit MAAT into their busy lives. The MAAT Clinician Manual provides a clearly written summary of the scientific literature on CRCI and detailed guidance for each visit, including an agenda outline, in-depth discussion, and accompanying fidelity checklist in the appendix. Designed to be used in conjunction with the Survivor Workbook, the Clinician Manual also includes the full text of the workbook in a separate appendix, giving clinicians convenient one-volume access to the complete material.Table of ContentsUse of This Manual Introduction Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Visit 6 Visit 7 Visit 8 Appendix 1. Survivor Workbook Appendix 2. Treatment Fidelity Checklists Appendix 3. Progressive Muscle Relaxation (PMR) Protocol References

    Out of stock

    £54.60

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account